Cargando…

The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects

Almost 15 years ago it was hypothesized that polymorphisms of genes encoding enzymes involved in folate metabolism could lead to aberrant methylation of peri-centromeric regions of chromosome 21, favoring its abnormal segregation during maternal meiosis. Subsequently, more than 50 small case-control...

Descripción completa

Detalles Bibliográficos
Autor principal: Coppedè, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479818/
https://www.ncbi.nlm.nih.gov/pubmed/26161087
http://dx.doi.org/10.3389/fgene.2015.00223
_version_ 1782378066858737664
author Coppedè, Fabio
author_facet Coppedè, Fabio
author_sort Coppedè, Fabio
collection PubMed
description Almost 15 years ago it was hypothesized that polymorphisms of genes encoding enzymes involved in folate metabolism could lead to aberrant methylation of peri-centromeric regions of chromosome 21, favoring its abnormal segregation during maternal meiosis. Subsequently, more than 50 small case-control studies investigated whether or not maternal polymorphisms of folate pathway genes could be risk factors for the birth of a child with Down syndrome (DS), yielding conflicting and inconclusive results. However, recent meta-analyses of those studies suggest that at least three of those polymorphisms, namely MTHFR 677C>T, MTRR 66A>G, and RFC1 80G>A, are likely to act as maternal risk factors for the birth of a child with trisomy 21, revealing also complex gene-nutrient interactions. A large-cohort study also revealed that lack of maternal folic acid supplementation at peri-conception resulted in increased risk for a DS birth due to errors occurred at maternal meiosis II in the aging oocyte, and it was shown that the methylation status of chromosome 21 peri-centromeric regions could favor recombination errors during meiosis leading to its malsegregation. In this regard, two recent case-control studies revealed association of maternal polymorphisms or haplotypes of the DNMT3B gene, coding for an enzyme required for the regulation of DNA methylation at centromeric and peri-centromeric regions of human chromosomes, with risk of having a birth with DS. Furthermore, congenital heart defects (CHD) are found in almost a half of DS births, and increasing evidence points to a possible contribution of lack of folic acid supplementation at peri-conception, maternal polymorphisms of folate pathway genes, and resulting epigenetic modifications of several genes, at the basis of their occurrence. This review summarizes available case-control studies and literature meta-analyses in order to provide a critical and up to date overview of what we currently know in this field.
format Online
Article
Text
id pubmed-4479818
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-44798182015-07-09 The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects Coppedè, Fabio Front Genet Genetics Almost 15 years ago it was hypothesized that polymorphisms of genes encoding enzymes involved in folate metabolism could lead to aberrant methylation of peri-centromeric regions of chromosome 21, favoring its abnormal segregation during maternal meiosis. Subsequently, more than 50 small case-control studies investigated whether or not maternal polymorphisms of folate pathway genes could be risk factors for the birth of a child with Down syndrome (DS), yielding conflicting and inconclusive results. However, recent meta-analyses of those studies suggest that at least three of those polymorphisms, namely MTHFR 677C>T, MTRR 66A>G, and RFC1 80G>A, are likely to act as maternal risk factors for the birth of a child with trisomy 21, revealing also complex gene-nutrient interactions. A large-cohort study also revealed that lack of maternal folic acid supplementation at peri-conception resulted in increased risk for a DS birth due to errors occurred at maternal meiosis II in the aging oocyte, and it was shown that the methylation status of chromosome 21 peri-centromeric regions could favor recombination errors during meiosis leading to its malsegregation. In this regard, two recent case-control studies revealed association of maternal polymorphisms or haplotypes of the DNMT3B gene, coding for an enzyme required for the regulation of DNA methylation at centromeric and peri-centromeric regions of human chromosomes, with risk of having a birth with DS. Furthermore, congenital heart defects (CHD) are found in almost a half of DS births, and increasing evidence points to a possible contribution of lack of folic acid supplementation at peri-conception, maternal polymorphisms of folate pathway genes, and resulting epigenetic modifications of several genes, at the basis of their occurrence. This review summarizes available case-control studies and literature meta-analyses in order to provide a critical and up to date overview of what we currently know in this field. Frontiers Media S.A. 2015-06-25 /pmc/articles/PMC4479818/ /pubmed/26161087 http://dx.doi.org/10.3389/fgene.2015.00223 Text en Copyright © 2015 Coppedè. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Coppedè, Fabio
The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects
title The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects
title_full The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects
title_fullStr The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects
title_full_unstemmed The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects
title_short The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects
title_sort genetics of folate metabolism and maternal risk of birth of a child with down syndrome and associated congenital heart defects
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479818/
https://www.ncbi.nlm.nih.gov/pubmed/26161087
http://dx.doi.org/10.3389/fgene.2015.00223
work_keys_str_mv AT coppedefabio thegeneticsoffolatemetabolismandmaternalriskofbirthofachildwithdownsyndromeandassociatedcongenitalheartdefects
AT coppedefabio geneticsoffolatemetabolismandmaternalriskofbirthofachildwithdownsyndromeandassociatedcongenitalheartdefects